RCS provides technology and visual services to help lead to a victory in the Southern District of Florida.
“Watson Pharmaceuticals Inc. won a U.S. patent ruling that may help its efforts to sell generic versions of Reckitt Benckiser Group Plc’s Mucinex cough medicine.
Watson wouldn’t infringe a Reckitt patent on the medicine, U.S. District Judge William Dimitrouleas in Fort Lauderdale, Florida, said today according to an order posted on the court’s website. The judge’s reasoning was sealed by the court.”…
Read full story here: